Evidence that stands up to scrutiny.
Economic modelling and strategic evidence generation for complex market access decisions.
We discover and drive innovative solutions to bring lifesaving treatments to patients around the world.
Established in 2008, we are a fully integrated team of outcomes researchers, health economists, and HTA experts.
.png){kind=icon}
Building evidence strategies for new healthcare technologies that align with JCA and HTA expectations from the outset.
Economic models designed to support pricing strategy, and market access across global and local settings.
Evidence synthesis and statistical analysis to generate robust evidence for HTA, pricing, and market access decisions.
Strategic and operational support for reimbursement applications, from global evidence planning through to local adaptation.
Supporting JCA readiness through proactive evidence planning and coordinated submission preparation.
Generating decision-ready real-world evidence to support HTA, regulatory, reimbursement, and evidence-generation decisions across global and local settings.
Clear and credible communication through scientific publications, training and other commercial materials.
Media & Success Stories
.jpg)
Stay in touch
Subscribe to Symmetron and stay up to date with recent news and announcements.
8 Devonshire Square,
London, EC2M 4PL, UK
